Innovative bioresource ICO - a decentralized company Biotech for the solution.

Innovative Bioresearch is an Italian biotechnology company whose main tasks are the introduction of innovations in the battle / fight against HIV, cancer and human regeneration. The company was founded by Italian researcher Jonathan Fior in 2014. An innovative bioresource ICO was created to raise funds to support innovative research in Innovative Bioresearch and develop an application that would ensure that all future clinical data collected by a modern, decentralized database were created and at the same time created a social platform for the seropositive community for HIV and other additional services.
The main problem today is a number of inconveniences in the currently existing centralized databases for clinical information. All data obtained in the course of medical scientific research are combined into one scientific article, which is then published in a scientific journal that previously passed a series of independent exams (also published in the public NIH database). After a new therapeutic strategy goes through all the stages of clinical research, many groups of researchers can begin experiments. After the final approval of therapy, treatment can be administered directly to patients. All this means that when the research team wants to conduct a specific clinical study, in fact, all patients have individual characteristics, so an individual treatment protocol is required.
A similar problem arises when administering approved treatment to patients, since a huge list of documentation is needed to determine the correct treatment protocol. This is not only a tedious process, but it can also lead to human error. Innovative Bioresearch proposes to solve such problems with access to clinical data, creating a new decentralized database based on block technology. This will be done in a new application called "You're not alone. " The application will be equipped with a convenient interface that allows clinicians to enter a wide range of individual parameters of each patient (age, height, stage of the disease, ethnicity, etc. ), treatment outcomes and clinical protocols.
ICO Tokens
• Platform: Ethereum
• Type: ERC20
• Pre ICO Price: 1 ETH = 498 INNBC
• Price ICO: 1 ETH = 415INNBC
• Soft cover Pre-ICO: 20 million INNBC
• Soft cover ICO: 30 million INNBC
• Hard cover: 50 million INNBK
• Preliminary ICO: May 1, 2018-15 June 2018. 20% bonus
• ICO: June 16, 2018-1 August 2018
Distribution of funds:
• 50% of all funds will be spent on further research into AIDS treatment methods;
• 20% will allocate for the development of the ecosystem;
• 15% will go to the development of the application;
• 10% for JDM cars;
• 5% of the remaining funds will be used to support and support the application.

Access to the use of INNBC tokens will be opened only after all the crypto currency has been sold during the ICO. In addition, holders of the currency Innovative Bioresearch will be able to sell it to other users, thereby providing the latest access to the platform.
Innovative Bioresearch wants to give all its investors something more, supporting the value of INNBC-tokens also physically. To this end, right after the end of the ICO, the company will open INNBC JDM ONLINE GARAGE, where investors can purchase JDM cars for their tokens.
Road map
2018:
• May - preliminary stage of MCO;
• June - the main stage of sale of tokens;
• August - launch of the platform;
• October - launching of HIV / AIDS research;
• December - the beginning of clinical trials.
2020:
• Initiation of four stages of clinical trials lasting 5-8 years.
• By 2025-2028, it is planned to purchase commercially available medicines. The launch of the application for the use of the clinical trials database is expected within 3-6 months after the end of the ICO.

Command
The basis of the innovative bioresource consists of three people, forming a strong and cohesive team:
• Jonathan Fior (owner, chief scientist, scientist and businessman)
• David Bossetti (manager of social networks)
• Alessandro Gatti (General Counsel).
Despite the fact that the composition of the project is small, Innovative Bioresearch uses many companies and research centers with more than 100 employees.

Conclusion
An unconventional approach to project financing is combined with a well-thought-out concept of its development. Its authors intend to challenge one of the most important problems of modern humanity - HIV / AIDS and cancer.
In addition to ICO to raise funds for project development, the team planned a service for selling cars for platform tokens and placing advertising advertisements to ensure a stable and constant inflow of funds for research. The platform will offer not only the sale of cars of such brands as Subaru, Skyline and Supra, but will also provide their delivery to customers in any tpoint of the world. The potential success of the project is also confirmed by the experience of its leader, who is already the author of promising research and scientific work in the search for ways of treating HIV and cancer.

For more information:
Website: https://www.innovativebioresearch.com/
WhitePaper:https://docs.wixstatic.com/ugd/b25952_f15e84ff60ea49879619ed747a40b54e.pdf
ANN: https://bitcointalk.org/index.php?topic=3378302.0

by:JoyJoy54

link profil:https://bitcointalk.org/index.php?action=profile;u=1813843;sa=summary